Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANFI
2901
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $310K | ﹤0.01% |
57,900
-11,600
| -17% | -$64.6K |
|
|
WRN
2902
Western Copper and Gold
WRN
$542M
| $309K | ﹤0.01% |
235,251
-30,389
| -11% | -$41.7K |
|
2903
SIFCO Industries
SIF
$124M
| $308K | ﹤0.01% |
38,000
-1,300
| -3% | -$10.6K |
|
|
FOMX
2904
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $307K | ﹤0.01% |
+62,014
| New | +$597K |
|
2905
Perma-Fix Environmental Services
PESI
$412M
| $306K | ﹤0.01% |
97,152
-11,548
| -11% | -$38.3K |
|
|
QBAK
2906
DELISTED
Qualstar Corp
QBAK
| $301K | ﹤0.01% |
57,102
+26,100
| +84% | +$121K |
|
2907
Optical Cable Corp
OCC
$149M
| $299K | ﹤0.01% |
96,600
+5,100
| +6% | +$16.8K |
|
|
KG
2908
Kestrel Group
KG
$66.3M
| $297K | ﹤0.01% |
1,061
-794
| -43% | -$261K |
|
2909
PDS Biotechnology
PDSB
$13.5M
| $297K | ﹤0.01% |
+1,630
| New | +$323K |
|
2910
Moog Inc Class B
MOG.B
| $296K | ﹤0.01% |
4,400
| – | – |
|
2911
Eterna Therapeutics
ERNA
$5.16M
| $294K | ﹤0.01% |
2
| – | – |
|
2912
Lithia Motors
LAD
$8.32B
| $292K | ﹤0.01% |
+3,410
| New | +$331K |
|
|
FABC
2913
Fabric.AI Inc
FABC
$18M
| $291K | ﹤0.01% |
14
+2
| +17% | +$44.5K |
|
2914
US Global Investors
GROW
$38.7M
| $291K | ﹤0.01% |
186,600
+14,100
| +8% | +$23.5K |
|
|
DLA
2915
DELISTED
Delta Apparel Inc.
DLA
| $291K | ﹤0.01% |
+16,500
| New | +$302K |
|
|
RTC
2916
DELISTED
Baijiayun Group
RTC
| $290K | ﹤0.01% |
17,320
+980
| +6% | +$14.3K |
|
|
BDSI
2917
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $290K | ﹤0.01% |
+152,800
| New | +$295K |
|
2918
Maui Land & Pineapple Co
MLP
$317M
| $289K | ﹤0.01% |
24,601
+4,301
| +21% | +$38.2K |
|
|
SMTX
2919
DELISTED
SMTC Corporation
SMTX
| $286K | ﹤0.01% |
223,199
+29,099
| +15% | +$40.4K |
|
|
CMBT
2920
CMB.TECH NV
CMBT
$4.86B
| $285K | ﹤0.01% |
+36,100
| New | +$291K |
|
|
STRM
2921
DELISTED
Streamline Health Solutions
STRM
| $284K | ﹤0.01% |
18,593
+2,813
| +18% | +$52.7K |
|
2922
Viper Energy
VNOM
$15.2B
| $281K | ﹤0.01% |
+15,634
| New | +$270K |
|
2923
Calumet Specialty Products
CLMT
$4.15B
| $280K | ﹤0.01% |
73,762
-460,938
| -86% | -$1.82M |
|
2924
Clearway Energy Class C
CWEN
$7.06B
| $280K | ﹤0.01% |
15,800
-98,700
| -86% | -$1.67M |
|
2925
Taylor Devices
TAYD
$172M
| $280K | ﹤0.01% |
20,300
-6,000
| -23% | -$86.9K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.